Ramsay Generale de Sante SA header image

Ramsay Generale de Sante SA

GDS

Equity

ISIN FR0000044471 / Valor 1247709

Euronext - Euronext Paris (2025-11-20)
EUR 8.98+0.45%

Ramsay Generale de Sante SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Ramsay Generale de Sante SA is a leading private hospital group in Europe, offering a wide range of medical and surgical specialties across general hospitals, follow-up care and rehabilitation clinics, and mental health facilities. With a strong focus on innovation and digitalization, the company invests significantly in new technologies and facility upgrades to enhance patient care and efficiency. Founded in 1964 by Australian entrepreneur Paul Ramsay AO, Ramsay Health Care has grown to become a global hospital group, employing over 50,000 people and treating nearly 3 million patients. Following the acquisition of Capio AB Group in 2018, Ramsay Santé has expanded its presence in Europe, now serving 7 million patients in five countries with 350 facilities and 36,000 employees.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.10.2025):

Ramsay Generale de Sante SA has released its financial results for the full year 2025, showcasing revenue growth, strategic operational expansions, and significant progress in sustainability initiatives.

Revenue Growth

The company reported a 2.4% increase in revenue from contracts with customers, reaching a total of $17.8 billion.

Profitability

Net profit after tax attributable to the owners of the parent was $197 million, reflecting a substantial decrease of 97.3% compared to the previous year.

Operational Expansion

Ramsay expanded its clinical trial network with over 300 active trials across 21 sites in Australia and continued its growth in the private hospital sector both in Australia and the UK.

Sustainability Achievements

The company met its FY25 target by reducing greenhouse gas emissions by 21% from the 2020 baseline and achieved 65% of its FY29 renewable energy installation goals.

Summarized from source with an LLMView Source

Key figures

-22.6%1Y
-54.8%3Y
-51.1%5Y

Performance

25.7%1Y
27.5%3Y
28.5%5Y

Volatility

Market cap

1140 M

Market cap (USD)

Daily traded volume (Shares)

154

Daily traded volume (Shares)

1 day high/low

12.1 / 11.75

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%EUR 35.45
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.60%CHF 95.34
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%CHF 133.00
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.59%CHF 70.10
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.97%CHF 67.40
medmix Ltd
medmix Ltd medmix Ltd Valor: 112967710
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%CHF 8.34
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%EUR 20.50
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%DKK 577.00
Ardent Health Partners Inc
Ardent Health Partners Inc Ardent Health Partners Inc Valor: 136301364
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 8.64
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252587
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%DKK 44.14